Ignite Creation Date:
2024-05-06 @ 10:09 AM
Last Modification Date:
2024-10-26 @ 12:25 PM
Study NCT ID:
NCT03170895
Status:
COMPLETED
Last Update Posted:
2020-03-30
First Post:
2017-05-26
Brief Title:
Combination of Sorafenib and Omacetaxine Mepesuccinate in Newly Diagnosed or RelapsedRefractory AML Carrying FLT3-ITD
Sponsor:
The University of Hong Kong
Organization:
The University of Hong Kong
Conditions & Keywords Data
Conditions:
| Name |
|---|
| FLT3-ITD Mutation |
| AML |
Keywords:
| Name | View |
|---|---|
| FLT3-ITD Acute Myeloid Leukemia AML | View |